These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1343670)
21. A comparative cross-sectional study on the prevalence and morbidity of schistosomiasis in a community in northeastern Brazil (1979-2010). Melo EV; Costa Wd; Conceição MJ; Coura JR Mem Inst Oswaldo Cruz; 2014 Jun; 109(3):340-4. PubMed ID: 24831552 [TBL] [Abstract][Full Text] [Related]
22. A municipal level approach to the management of schistosomiasis control in Peri-Peri, MG, Brazil. Coura Filho P; Rocha RS; de Lima E Costa MF; Katz N Rev Inst Med Trop Sao Paulo; 1992; 34(6):543-8. PubMed ID: 1342123 [TBL] [Abstract][Full Text] [Related]
23. [Morbidity of schistosomiasis in Brazil. IV--Course in treated patients and their controls]. dos Santos ML; Coura JR Mem Inst Oswaldo Cruz; 1986; 81(1):53-60. PubMed ID: 3099121 [TBL] [Abstract][Full Text] [Related]
24. Tolerance of Kenyan Schistosoma mansoni to oxamniquine. Coles GC; Mutahi WT; Kinoti GK; Bruce JI; Katz N Trans R Soc Trop Med Hyg; 1987; 81(5):782-5. PubMed ID: 3130689 [TBL] [Abstract][Full Text] [Related]
25. [Morbidity of schistosomiasis mansoni in Brazil. Developmental study in an endemic area over a 10-year period]. Coura JR; Conceição MJ; Pereira JB Mem Inst Oswaldo Cruz; 1984; 79(4):447-53. PubMed ID: 6335910 [TBL] [Abstract][Full Text] [Related]
26. Assessment of schistosomiasis in the semi-arid Northeast region of Brazil: the São Francisco River large-scale water transposition project. Favre TC; Fernandez MA; Beck LC; Guimarães RJ; Pieri OS; Thiengo SA Rev Soc Bras Med Trop; 2016 Apr; 49(2):252-7. PubMed ID: 27192599 [TBL] [Abstract][Full Text] [Related]
27. [Prevalence and worm burden of Schistosomiasis mansoni before and after collective treatment in Jaboatão dos Guararapes, Pernambuco, Brazil]. Gomes AC; Galindo JM; Lima NN; Silva ÉV Epidemiol Serv Saude; 2016; 25(2):243-250. PubMed ID: 27869942 [TBL] [Abstract][Full Text] [Related]
28. Repeated mass treatment of schistosomiasis mansoni: experience in hyperendemic areas of Brazil. I. Parasitological effects and morbidity. Kloetzel K; Schuster NH Trans R Soc Trop Med Hyg; 1987; 81(3):365-70. PubMed ID: 3120363 [TBL] [Abstract][Full Text] [Related]
29. Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel. Gryseels B; Nkulikyinka L Trans R Soc Trop Med Hyg; 1989; 83(2):219-28. PubMed ID: 2514474 [TBL] [Abstract][Full Text] [Related]
30. Study of Schistosoma mansoni isolates from patients with failure of treatment with oxamniquine. Conceição MJ; Argento CA; Corrêa A Mem Inst Oswaldo Cruz; 2000; 95(3):375-80. PubMed ID: 10800196 [TBL] [Abstract][Full Text] [Related]
31. Long-term effect of mass chemotherapy, transmission and risk factors for Schistosoma mansoni infection in very low endemic communities of Venezuela. Hofstede SN; Tami A; van Liere GA; Ballén D; Incani RN Acta Trop; 2014 Dec; 140():68-76. PubMed ID: 25128702 [TBL] [Abstract][Full Text] [Related]
33. Schistosomiasis mansoni in Burundi: progress in its control since 1985. Engels D; Ndoricimpa J; Gryseels B Bull World Health Organ; 1993; 71(2):207-14. PubMed ID: 8490984 [TBL] [Abstract][Full Text] [Related]
34. Current status of Schistosoma mansoni and the factors associated with infection two years following mass drug administration programme among primary school children in Mwea irrigation scheme: A cross-sectional study. Masaku J; Madigu N; Okoyo C; Njenga SM BMC Public Health; 2015 Aug; 15():739. PubMed ID: 26231050 [TBL] [Abstract][Full Text] [Related]
35. [Control of schistosomiasis mansoni in an area of low transmission]. Dias LC; Marçal Júnior O; Glasser CM; Kanamura HY; Hotta LK Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():233-9. PubMed ID: 1343901 [TBL] [Abstract][Full Text] [Related]
36. A case of Schistosoma mansoni infection treated during the prepatent period. Enk MJ; Katz N; Zech Coelho PM Nat Clin Pract Gastroenterol Hepatol; 2008 Feb; 5(2):112-5. PubMed ID: 18253140 [TBL] [Abstract][Full Text] [Related]
37. [Efficacy of UK 4271 (oxamniquine, Pfizer) in Schistosoma mansoni bilharziasis in western Africa (parasitological and serological study of 252 children)]. Nozais JP; Geunier M Bull Soc Pathol Exot Filiales; 1979; 72(2):153-64. PubMed ID: 527159 [TBL] [Abstract][Full Text] [Related]
38. Studies on the epidemiology of schistosomiasis in Liberia: the prevalence and intensity of schistosomal infections in Bong County and the bionomics of the snail intermediate hosts. Dennis E; Vorkpor P; Holzer B; Hanson A; Saladin B; Saladin K; Degrémont A Acta Trop; 1983 Sep; 40(3):205-29. PubMed ID: 6138973 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of hepatic fibrosis after oxamniquine therapy of murine schistosomiasis. Morcos SH; Mansour MM; Khayyal MT; Saleh S; Ishak EA; Girgis NI Ann Trop Med Parasitol; 1992 Oct; 86(5):511-6. PubMed ID: 1288432 [TBL] [Abstract][Full Text] [Related]
40. [A comprehensive health plan in combatting schistosomiasis in the State of Maranhão, Brazil]. Melo JE; Lima BB Rev Bras Malariol Doencas Trop; 1986; 38():87-102. PubMed ID: 3151706 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]